Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
nuclear pore complex interacting protein pseudogene 1 (NPIPP1, also referred to as NPIPA4P) likely represents a gene annotation for a pseudogene, not a functional protein. There is no validated evidence that this molecule is a functional component of nuclear pore complexes, nor is there any indication that it is a therapeutic target or clinically relevant biomarker. Pseudogenes are genetic sequences resembling protein-coding genes but are generally non-functional, lacking expression of a functional protein product and do not participate in known biological processes nor interact with drugs. The term NPIPP1 and its aliases refer to a hypothetical or predicted pseudogene rather than a true molecular target[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on nuclear pore complex interacting protein pseudogene 1 (NPIPP1).